Inverness acquires Alere
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical Innovations continues its acquisition spree with the $302 million purchase of Alere, a provider of health and care-management services for patients with heart failure and other chronic illnesses, in agreement announced Oct. 24. The purchase complements Inverness's cardiac management and diagnostic technologies, and is consistent with the firm's overall acquisition strategy, according to CEO Ron Zwanziger (1"The Gray Sheet" Sept. 3, 2007, p. 9). The transaction, which includes $125 million in cash and $177 million in Inverness common stock, is expected to close at the end of 2007. Alere is expected to have 2007 revenues of $77 million
You may also be interested in...
Inverness becomes Alere
Inverness Medical Innovations plans to change its name to Alere as part of a strategy to leverage its combined offerings and maximize visibility and growth, the firm announces May 18. The diagnostics and health management services firm currently uses the Alere name (which means "to nurture" in Latin) for its health management services. "Therefore, the name already benefits from recognition within the healthcare community," the firm says. Inverness acquired health management services firm Alere in 2007 and will seek shareholder approval for the name change at its July 14 annual meeting; the company's stock symbol would change from "IMA" to "ALR" (1"The Gray Sheet" Oct. 29, 2007)
Inverness buys Free & Clear
Inverness Medical Innovations expands its health management services business through the acquisition of Seattle-based Free & Clear for $100 million, plus up to $30 million in future milestone payments, announced Sept. 21. Free & Clear, which provides online and phone-based behavioral coaching to address health risks associated with tobacco, poor nutrition, inactivity and stress, reported 2008 sales of $47.1 million. Inverness, which also makes diagnostics, will combine Free & Clear with its Alere health management services business (1"The Gray Sheet" Oct. 29, 2007)
Inverness Continues 2007 Buying Spree, Adds Matritech Assets For $36 Mil.
Inverness Medical continues to build its worldwide distribution capabilities with the $36 million purchase of Matritech's assets, the firm's tenth acquisition or joint venture announced this year